We consider that the identification of the susceptibility polymorphisms in PADI2 is important from the clinical viewpoint; however, the clinical perspective of our findings related to the presence of a positive serologic status for multiple autoantibodies and the clinical manifestations of RA at an early onset age deserves replication studies amongst populations. This evidence concerns the gene PADI2 and rheumatoid arthritis.